SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > NanoViricides Inc. (NNVC)

fyi...Todayht

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Smooth Member Profile
 
Followed By 45
Posts 4,887
Boards Moderated 1
Alias Born 03/02/07
160x600 placeholder
NanoViricides Has Filed Annual Report, Says Company Has Sufficient Cash To Advance Into Clinical Trials "PR Newswire (US)" - 9/29/2017 7:30:00 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 9/28/2017 4:51:22 PM
NanoViricides, Inc. Announces its CEO Dr. Seymour to Present at the 19th Annual Rodman & Renshaw Global Investment Conference... "PR Newswire (US)" - 9/11/2017 9:04:00 AM
NanoViricides Reports Its Drug Candidates Significantly Reduced the Extent of Shingles Virus Infection of Human Skin "PR Newswire (US)" - 7/10/2017 7:00:00 AM
NanoViricides' Poster "Novel NanoviricidesĀ® Highly Effective Against Varicella Zoster Virus in Cell Culture" to be Presented... "PR Newswire (US)" - 6/26/2017 9:00:00 AM
NanoViricides Abstract Accepted for Poster Presentation at the 2017 Annual Meeting of American Society of Virology "PR Newswire (US)" - 6/20/2017 7:00:00 AM
NanoViricides CEO to Present Information on Its Topical Shingles Treatment At the 2017 Marcum Investor Conference in New York... "PR Newswire (US)" - 6/13/2017 7:00:00 AM
NanoViricides Reports Excellent Inhibitory Effects of Its Topical Shingles Treatment Candidates Against VZV in Multiple Cell ... "PR Newswire (US)" - 6/6/2017 5:30:00 PM
NanoViricides Files Quarterly Report for Period Ending 2017-03-31 "PR Newswire (US)" - 5/16/2017 7:50:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/15/2017 5:03:04 PM
NanoViricides CEO Dr. Seymour to Present an Update on the Company at The Planet Microcap Showcase - 2017 in Las Vegas; Compan... "PR Newswire (US)" - 4/26/2017 5:00:00 PM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 4/26/2017 6:02:18 AM
Securities Registration Statement (simplified Form) (s-3/a) "Edgar (US Regulatory)" - 4/18/2017 4:57:18 PM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 3/1/2017 6:10:07 AM
NanoViricides Files Quarterly Report for Period Ending 2016-12-31 "PR Newswire (US)" - 2/16/2017 7:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 2/14/2017 6:02:28 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/13/2017 5:33:10 PM
NanoViricides Reports the Company's Director Dr. Boniuk Converted Series B Debenture to Equity Effectively Raising $5M in New... "PR Newswire (US)" - 2/13/2017 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/3/2017 1:27:25 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/15/2016 4:54:24 PM
NanoViricides Publishes a Letter from the CEO to Shareholders on its Website "PR Newswire (US)" - 12/1/2016 7:00:00 AM
NanoViricides Files Quarterly Report for Period Ending 2016-09-30 "PR Newswire (US)" - 11/15/2016 7:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/14/2016 5:04:40 PM
NanoViricides President Dr. Diwan Gave Invited Talks on Regulatory Aspects of Nanomedicines "PR Newswire (US)" - 11/7/2016 7:00:00 AM
NanoViricides Signs Agreement with SUNY Upstate Medical Center for Testing of Its Drug Candidates for the Treatment of Shingl... "PR Newswire (US)" - 10/31/2016 7:00:00 AM
Smooth   Wednesday, 11/18/09 11:30:22 AM
Re: None
Post # of 135390 
fyi...Today

http://www.chemshow.com/includes/nano.pdf

3.30 p.m. – 5.00 p.m.
Session IV – The Intersection of Nanotechnology and Biology
Session Chair and Moderator – Jim Hurd, Director, NanoScience Exchange, San Francisco, CA
Prof. Brij Moudgil, Distinguished Professor and Alumni Professor of Materials Science and Engineering,
and Director of Particle Engineering Research Center, University of Florida, Gainesville, FL
Dr. Anil Diwan, President and Chairman, NanoViricides, Inc., West haven, CT,
"Nanoviricides - Novel Antiviral Agents Against HIV, Influenza, and Many Other
Diseases"
• What is a nanoviricide : "Find-Encapsulate-Destroy" antiviral strategy
• FluCide(tm) - Pan-Influenza nanoviricide against pandemic, epidemic influenzas, bird flu,
high path viruses
• HivCide(tm) - Anti-HIV nanoviricide was superior to oral HAART cocktail therapy in
animal models
• Broad-spectrum nanoviricides - A low cost approach against Neglected Tropical Diseases


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist